The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 7 of 25
Back to Result List

Circulating microRNA Expression in Cushing’s Syndrome

Please always quote using this URN: urn:nbn:de:bvb:20-opus-229761
  • Context Cushing’s syndrome (CS) is a rare disease of endogenous hypercortisolism associated with high morbidity and mortality. Diagnosis and classification of CS is still challenging. Objective Circulating microRNAs (miRNAs) are minimally invasive diagnostic markers. Our aim was to characterize the circulating miRNA profiles of CS patients and to identify distinct profiles between the two major CS subtypes. Methods We included three groups of patients from the German Cushing’s registry: ACTH-independent CS (Cortisol-Producing-Adenoma;Context Cushing’s syndrome (CS) is a rare disease of endogenous hypercortisolism associated with high morbidity and mortality. Diagnosis and classification of CS is still challenging. Objective Circulating microRNAs (miRNAs) are minimally invasive diagnostic markers. Our aim was to characterize the circulating miRNA profiles of CS patients and to identify distinct profiles between the two major CS subtypes. Methods We included three groups of patients from the German Cushing’s registry: ACTH-independent CS (Cortisol-Producing-Adenoma; CPA), ACTH-dependent pituitary CS (Cushing’s Disease; CD), and patients in whom CS had been ruled out (controls). Profiling of miRNAs was performed by next-generation-sequencing (NGS) in serum samples of 15 CS patients (each before and after curative surgery) and 10 controls. Significant miRNAs were first validated by qPCR in the discovery cohort and then in an independent validation cohort of 20 CS patients and 11 controls. Results NGS identified 411 circulating miRNAs. Differential expression of 14 miRNAs were found in the pre- and postoperative groups. qPCR in the discovery cohort validated 5 of the significant miRNAs from the preoperative group analyses. Only, miR-182-5p was found to be significantly upregulated in the CD group of the validation cohort. Comparing all CS samples as a group with the controls did not reveal any significant differences in expression. Outcome In conclusion, our study identified miR-182-5p as a possible biomarker for CD, which has to be validated in a prospective cohort. Furthermore, our results suggest that presence or absence of ACTH might be at least as relevant for miRNA expression as hypercortisolism itself.show moreshow less

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Sharmilee Vetrivel, Ru Zhang, Mareen Engel, Barbara Altieri, Leah Braun, Andrea Osswald, Martin Bidlingmaier, Martin Fassnacht, Felix Beuschlein, Martin Reincke, Alon Chen, Silviu Sbiera, Anna Riester
URN:urn:nbn:de:bvb:20-opus-229761
Document Type:Journal article
Faculties:Medizinische Fakultät / Medizinische Klinik und Poliklinik I
Language:English
Parent Title (English):Frontiers in Endocrinology
ISSN:1664-2392
Year of Completion:2021
Volume:12
Article Number:620012
Source:Frontiers in Endocrinology 2021, 12;620012. DOI: 10.3389/fendo.2021.620012
DOI:https://doi.org/10.3389/fendo.2021.620012
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:ACTH; biomarker; cortisol; cortisol-producing adenoma; hypercortisolism; miR-182-5p; miR-183 cluster; miRNA
Release Date:2022/02/02
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International